NewMeco's Botulinum Toxin Product 'NEWLUX' Receives Product Approval in Azerbaijan
Medytox announced on June 30 that its affiliate, NewMeco, has received product approval for the botulinum toxin product 'NEWLUX' from the Ministry of Health (MOH) of Azerbaijan.
Azerbaijan, with its capital Baku, has a steadily growing medical tourism market and rapidly increasing demand for cosmetic procedures. To accelerate the market entry of 'NEWLUX,' NewMeco plans to actively leverage the local partnerships that Medytox has established over many years. Medytox has been solidifying its market presence in Azerbaijan since launching its botulinum toxin product 'Medytoxin' (export name: QNox) in 2019 and four types of hyaluronic acid fillers under the brand 'Neuramis' in 2020.
NewMeco plans to use Azerbaijan as a base to pursue additional product approvals in neighboring countries, focusing on developing overseas sales channels and expanding exports. A NewMeco representative stated, "With this approval, we have secured a strategic foothold for entering neighboring markets," adding, "We will strengthen local partnerships and focus on country-specific strategies to increase the global market share of 'NEWLUX.'"
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
'NEWLUX' is a next-generation botulinum toxin product developed by NewMeco. It boasts enhanced production yield and quality due to its latest manufacturing processes. It is the first 900 KDa (kilodalton) product to use only non-animal-derived culture media during the bacterial culturing stage, thereby eliminating the risk of contamination from animal-derived ingredients. The process also minimizes chemical treatment steps, reducing the denaturation of active neurotoxin proteins. Since 2024, the company has been accelerating its expansion into Latin America, Asia, and Europe, beginning with Peru and followed by Thailand, Georgia, Bolivia, Moldova, the Dominican Republic, El Salvador, and Ukraine.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.